Eikon Therapeutics, Inc. Common Stock (EIKN) vs Tilray Brands, Inc. (TLRY)

A side-by-side comparison of Eikon Therapeutics, Inc. Common Stock and Tilray Brands, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Eikon Therapeutics, Inc. Common Stock logo
EIKN
Eikon Therapeutics, Inc. Common Stock
$407M
$7.51HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Tilray Brands, Inc. logo
TLRY
Tilray Brands, Inc.
$423M
$3.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — EIKN vs TLRY

growth of $100 · dividends reinvested · last 1y
EIKN -49.7% (-49.7%/yr)TLRY -51.1% (-51.1%/yr)EIKN compounded faster over this window
6080100Start $100$50$49
EIKN TLRY

EIKN vs TLRY: by the numbers

  • •TLRY is the larger company ($423M vs $407M market cap).
  • •Both run net losses; EIKN's is the smaller (0.00% vs -12.90% net margin).

Metrics side by side

Valuation

MetricEIKNTLRY
P/S ratioN/A0.37
P/B ratio0.870.26
EV / EBITDAN/A22.89

Profitability

MetricEIKNTLRY
Gross margin0.00%27.57%
Operating margin0.00%-5.18%
Net margin0.00%-12.90%
ROE-69.06%-9.23%
ROIC-46.16%-2.98%

Growth (annualized)

MetricEIKNTLRY
Revenue CAGR (5Y)N/A17.11%
Total return CAGR (5Y)N/A-49.30%

Go deeper

Full EIKN analysisFull TLRY analysisInteractive comparison tool

Dig into the metrics

Eikon Therapeutics, Inc. Common Stock ROETilray Brands ROEEikon Therapeutics, Inc. Common Stock operating marginTilray Brands operating marginEikon Therapeutics, Inc. Common Stock revenue growthTilray Brands revenue growthEikon Therapeutics, Inc. Common Stock free cash flowTilray Brands free cash flow

Eikon Therapeutics, Inc. Common Stock & Tilray Brands appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.